Rankings
▼
Calendar
KMDA FY 2022 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$520M
FY 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$129M
+24.8% YoY
Gross Profit
$47M
36.1% margin
Operating Income
$5M
3.5% margin
Net Income
-$2M
-1.8% margin
EPS (Diluted)
$-0.05
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$25M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$322M
Total Liabilities
$146M
Stockholders' Equity
$176M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$129M
$104M
+24.8%
Gross Profit
$47M
$30M
+54.0%
Operating Income
$5M
-$696,000
+751.1%
Net Income
-$2M
-$2M
-4.1%
← Q4 2021
All Quarters
Q1 2022 →